论文部分内容阅读
目的:探究分析治疗新生儿缺氧缺血性脑病采用脑蛋白水解物联合复方丹参治疗的临床体会。方法:选择2013年1月至2014年12月在该院就诊并接受住院治疗的84例新生儿缺氧缺血性脑病患者作为研究对象,随机评分为两组各42例,对照组42例患者均采用基本常规性治疗,实验组42例患者在基本常规性治疗上采用脑蛋白水解物联合复方丹参治疗方式,对比实验组与对照组的临床治疗效果,并进行分析。结果:实验组所有患者的总有效率为88.10%,对照组所有患者的总有效率为66.66%,实验组的临床治疗效果显著优于对照组(P<0.05)。结论:脑蛋白水解物联合复方丹参治疗新生儿缺氧缺血性脑病具有较好的临床治疗体会,值得临床广泛推广。
Objective: To explore the clinical experience of treatment of neonatal hypoxic-ischemic encephalopathy with brain protein hydrolyzate combined with compound Salvia. Methods: A total of 84 neonates with hypoxic-ischemic encephalopathy who were hospitalized and hospitalized from January 2013 to December 2014 were selected as study subjects and randomly assigned to 42 patients in each of two groups and 42 patients in control group All of the 42 patients in the experimental group were treated with brain protein hydrolysates combined with compound Salvia miltiorrhiza in the routine routine treatment. The clinical effects of the experimental group and the control group were compared and analyzed. Results: The total effective rate of all the patients in experimental group was 88.10%. The total effective rate of all the patients in control group was 66.66%. The clinical treatment effect of experimental group was significantly better than that of control group (P <0.05). Conclusion: The brain protein hydrolyzate combined with Salvia miltiorrhiza for neonatal hypoxic-ischemic encephalopathy has a better clinical experience, it is worth widely clinical promotion.